403 related articles for article (PubMed ID: 26791247)
1. Cell-Based Therapy for Degenerative Retinal Disease.
Zarbin M
Trends Mol Med; 2016 Feb; 22(2):115-134. PubMed ID: 26791247
[TBL] [Abstract][Full Text] [Related]
2. Gene and Induced Pluripotent Stem Cell Therapy for Retinal Diseases.
Maeda A; Mandai M; Takahashi M
Annu Rev Genomics Hum Genet; 2019 Aug; 20():201-216. PubMed ID: 31018110
[TBL] [Abstract][Full Text] [Related]
3. Stem cells in retinal regeneration: past, present and future.
Ramsden CM; Powner MB; Carr AJ; Smart MJ; da Cruz L; Coffey PJ
Development; 2013 Jun; 140(12):2576-85. PubMed ID: 23715550
[TBL] [Abstract][Full Text] [Related]
4. Protective Effects of Human iPS-Derived Retinal Pigmented Epithelial Cells in Comparison with Human Mesenchymal Stromal Cells and Human Neural Stem Cells on the Degenerating Retina in rd1 mice.
Sun J; Mandai M; Kamao H; Hashiguchi T; Shikamura M; Kawamata S; Sugita S; Takahashi M
Stem Cells; 2015 May; 33(5):1543-53. PubMed ID: 25728228
[TBL] [Abstract][Full Text] [Related]
5. Stem cell based therapies for age-related macular degeneration: The promises and the challenges.
Nazari H; Zhang L; Zhu D; Chader GJ; Falabella P; Stefanini F; Rowland T; Clegg DO; Kashani AH; Hinton DR; Humayun MS
Prog Retin Eye Res; 2015 Sep; 48():1-39. PubMed ID: 26113213
[TBL] [Abstract][Full Text] [Related]
6. Retinal pigment epithelium.
Klimanskaya I
Methods Enzymol; 2006; 418():169-94. PubMed ID: 17141036
[TBL] [Abstract][Full Text] [Related]
7. Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa.
Li Y; Tsai YT; Hsu CW; Erol D; Yang J; Wu WH; Davis RJ; Egli D; Tsang SH
Mol Med; 2012 Dec; 18(1):1312-9. PubMed ID: 22895806
[TBL] [Abstract][Full Text] [Related]
8. Stem Cell Treatment for Age-Related Macular Degeneration: the Challenges.
Singh MS; MacLaren RE
Invest Ophthalmol Vis Sci; 2018 Mar; 59(4):AMD78-AMD82. PubMed ID: 30025109
[No Abstract] [Full Text] [Related]
9. [Adult human retinal pigment epithelial cells - a potential source of cells for regeneration retina].
Kuznetsova AV; Grirorian ÉN; Aleksandrova MA
Tsitologiia; 2011; 53(6):505-12. PubMed ID: 21870507
[TBL] [Abstract][Full Text] [Related]
10. Transplantation of rat embryonic stem cell-derived retinal cells restores visual function in the Royal College of Surgeons rats.
Wu H; Li J; Mao X; Li G; Xie L; You Z
Doc Ophthalmol; 2018 Oct; 137(2):71-78. PubMed ID: 30074097
[TBL] [Abstract][Full Text] [Related]
11. Generation of Transplantable Retinal Pigmented Epithelial (RPE) Cells for Treatment of Age-Related Macular Degeneration (AMD).
Surendran H; Rathod RJ; Pal R
Methods Mol Biol; 2019; 2045():283-298. PubMed ID: 29896658
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat.
Carr AJ; Vugler AA; Hikita ST; Lawrence JM; Gias C; Chen LL; Buchholz DE; Ahmado A; Semo M; Smart MJ; Hasan S; da Cruz L; Johnson LV; Clegg DO; Coffey PJ
PLoS One; 2009 Dec; 4(12):e8152. PubMed ID: 19997644
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of human induced pluripotent stem cell-derived retinal cell transplantation in Pde6b knockout rats.
Yang JM; Chung S; Yun K; Kim B; So S; Kang S; Kang E; Lee JY
Exp Mol Med; 2021 Apr; 53(4):631-642. PubMed ID: 33828232
[TBL] [Abstract][Full Text] [Related]
14. Immunologic Rejection of Transplanted Retinal Pigmented Epithelium: Mechanisms and Strategies for Prevention.
Petrash CC; Palestine AG; Canto-Soler MV
Front Immunol; 2021; 12():621007. PubMed ID: 34054796
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stem Cell-Based Therapy for Retinal Degenerative Diseases: Experimental Models and Clinical Trials.
Holan V; Palacka K; Hermankova B
Cells; 2021 Mar; 10(3):. PubMed ID: 33799995
[TBL] [Abstract][Full Text] [Related]
16. Utilizing stem cell-derived RPE cells as a therapeutic intervention for age-related macular degeneration.
Westenskow PD; Kurihara T; Friedlander M
Adv Exp Med Biol; 2014; 801():323-9. PubMed ID: 24664714
[TBL] [Abstract][Full Text] [Related]
17. Advancing a Stem Cell Therapy for Age-Related Macular Degeneration.
O'Neill HC; Limnios IJ; Barnett NL
Curr Stem Cell Res Ther; 2020; 15(2):89-97. PubMed ID: 31854278
[TBL] [Abstract][Full Text] [Related]
18. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies.
Schwartz SD; Regillo CD; Lam BL; Eliott D; Rosenfeld PJ; Gregori NZ; Hubschman JP; Davis JL; Heilwell G; Spirn M; Maguire J; Gay R; Bateman J; Ostrick RM; Morris D; Vincent M; Anglade E; Del Priore LV; Lanza R
Lancet; 2015 Feb; 385(9967):509-16. PubMed ID: 25458728
[TBL] [Abstract][Full Text] [Related]
19. Stem Cell-Based RPE Therapy for Retinal Diseases: Engineering 3D Tissues Amenable for Regenerative Medicine.
Ben M'Barek K; Habeler W; Monville C
Adv Exp Med Biol; 2018; 1074():625-632. PubMed ID: 29721996
[TBL] [Abstract][Full Text] [Related]
20. Reproducible production and image-based quality evaluation of retinal pigment epithelium sheets from human induced pluripotent stem cells.
Ye K; Takemoto Y; Ito A; Onda M; Morimoto N; Mandai M; Takahashi M; Kato R; Osakada F
Sci Rep; 2020 Sep; 10(1):14387. PubMed ID: 32873827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
